Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Magnani, P. Brosselin, J. Beaute, N. Vergnes, R. Mouy, M. Debré, F. Suarez, O. Hermine, O. Lortholary, S. Blanche, A. Fischer, N. Mahlaoui (2014)
Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease.The Journal of allergy and clinical immunology, 134 3
N. Mahlaoui, I. Pellier, Cécile Mignot, J. Jais, C. Bilhou-Nabera, D. Moshous, B. Neven, C. Picard, G. Saint-Basile, M. Cavazzana‐Calvo, S. Blanche, A. Fischer (2013)
Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome.Blood, 121 9
J. Fernandes, V. Rocha, M. Labopin, B. Neven, D. Moshous, A. Gennery, W. Friedrich, F. Porta, C. Heredia, D. Wall, Y. Bertrand, P. Veys, M. Slatter, A. Schulz, K. Chan, M. Grimley, M. Ayas, T. Güngör, W. Ebell, C. Bonfim, K. Kałwak, P. Taupin, P. Taupin, S. Blanche, H. Gaspar, Paul Landais, Paul Landais, Alain Fischer, Alain Fischer, E. Gluckman, M. Cavazzana‐Calvo, M. Cavazzana‐Calvo (2012)
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?Blood, 119 12
M. Jordan, David Hildeman, J. Kappler, P. Marrack (2004)
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.Blood, 104 3
R. Seger, T. Gungor, B. Belohradsky, S. Blanche, P. Bordigoni, P. Bartolomeo, T. Flood, P. Landais, S. Müller, H. Ozsahin, J. Passwell, F. Porta, S. Slavin, N. Wulffraat, F. Zintl, A. Nagler, A. Cant, A. Fischer (2002)
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.Blood, 100 13
Daniel Teschner, E. Distler, D. Wehler, Michaela Frey, D. Marandiuc, K. Langeveld, Matthias Theobald, Simone Thomas, Wolfgang Herr (2014)
Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxisBone Marrow Transplantation, 49
Karin Engelhardt, S. McGhee, S. Winkler, A. Sassi, C. Woellner, G. López-Herrera, Andrew Chen, H. Kim, M. Lloret, I. Schulze, S. Ehl, J. Thiel, D. Pfeifer, H. Veelken, T. Niehues, K. Siepermann, S. Weinspach, I. Reisli, S. Keleş, F. Genel, N. Kutuculer, Yıldız, Camcıoğlu, A. Somer, E. Karakoc‐Aydiner, I. Barlan, A. Gennery, A. Metin, A. Değerliyurt, M. Pietrogrande, M. Yeganeh, Z. Baz, S. Al-Tamemi, C. Klein, J. Puck, S. Holland, E. McCabe, B. Grimbacher, T. Chatila (2009)
Immune deficiencies, infection, and systemic immune disordersLarge deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndromeThe Journal of Allergy and Clinical Immunology, 124
E. Chu, A. Freeman, Huie Jing, E. Cowen, Joie Davis, H. Su, S. Holland, M. Turner (2012)
Cutaneous manifestations of DOCK8 deficiency syndrome.Archives of dermatology, 148 1
C. Antoine, S. Müller, A. Cant, M. Cavazzana‐Calvo, P. Veys, J. Vossen, A. Fasth, C. Heilmann, N. Wulffraat, R. Seger, S. Blanche, W. Friedrich, M. Abinun, G. Davies, R. Bredius, A. Schulz, P. Landais, A. Fischer (2003)
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99The Lancet, 361
J. Montfrans, A. Hoepelman, S. Otto, M. Gijn, L. Corput, R. Weger, Linda Monaco-Shawver, P. Banerjee, E. Sanders, C. Zijde, M. Betts, J. Orange, A. Bloem, K. Tesselaar (2012)
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia.The Journal of allergy and clinical immunology, 129 3
Ulrike Zeilhofer, M. Ashworth, P. Amrolia, A. Rao, R. Chiesa, P. Veys, K. Rao (2013)
Pulmonary hypertension following haematopoietic stem cell transplantation for primary haemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 60
M. Burg, A. Gennery (2011)
Educational paperEuropean Journal of Pediatrics, 170
S. Pai, B. Logan, Linda Griffith, R. Buckley, R. Parrott, C. Dvorak, N. Kapoor, I. Hanson, A. Filipovich, S. Jyonouchi, K. Sullivan, T. Small, L. Burroughs, S. Skoda-Smith, A. Haight, A. Grizzle, M. Pulsipher, K. Chan, R. Fuleihan, E. Haddad, B. Loechelt, V. Aquino, A. Gillio, Jeffrey Davis, A. Knutsen, Angela Smith, T. Moore, M. Schroeder, F. Goldman, J. Connelly, M. Porteus, Q. Xiang, W. Shearer, T. Fleisher, D. Kohn, J. Puck, L. Notarangelo, M. Cowan, R. O'reilly (2014)
Transplantation outcomes for severe combined immunodeficiency, 2000-2009.The New England journal of medicine, 371 5
A. Aiuti, F. Cattaneo, S. Galimberti, U. Benninghoff, B. Cassani, Luciano Callegaro, S. Scaramuzza, G. Andolfi, M. Mirolo, I. Brigida, A. Tabucchi, F. Carlucci, M. Eibl, M. Aker, S. Slavin, H. Al-Mousa, Abdulaziz Ghonaium, A. Ferster, A. Duppenthaler, L. Notarangelo, U. Wintergerst, R. Buckley, M. Bregni, S. Marktel, M. Valsecchi, P. Rossi, F. Ciceri, R. Miniero, C. Bordignon, M. Roncarolo (2009)
Gene therapy for immunodeficiency due to adenosine deaminase deficiency.The New England journal of medicine, 360 5
T. Fleisher (2015)
Transplantation Outcomes for Severe Combined Immunodeficiency 2000–2009Pediatrics, 136
C. Booth, Kimberly Gilmour, P. Veys, A. Gennery, M. Slatter, H. Chapel, Paul Heath, Colin Steward, O. Smith, A. O'meara, Hilary Kerrigan, N. Mahlaoui, M. Cavazzana‐Calvo, A. Fischer, D. Moshous, S. Blanche, J. Schmid, S. Latour, G. Saint-Basile, M. Albert, G. Notheis, N. Rieber, B. Strahm, H. Ritterbusch, A. Lankester, Nico Hartwig, I. Meyts, A. Plebani, A. Soresina, A. Finocchi, C. Pignata, E. Cirillo, S. Bonanomi, C. Peters, K. Kałwak, S. Pašić, P. Sedláček, J. Jazbec, H. Kanegane, Kim Nichols, I. Hanson, N. Kapoor, E. Haddad, M. Cowan, S. Choo, Joanne Smart, Peter Arkwright, H. Gaspar (2011)
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.Blood, 117 1
H. Boztug, Cäcilia Karitnig-Weiss, B. Ausserer, E. Renner, M. Albert, J. Sawalle-Belohradsky, B. Belohradsky, G. Mann, E. Horcher, Alexandra Rümmele-Waibel, R. Geyeregger, Karoly Lakatos, C. Peters, A. Lawitschka, S. Matthes‐Martin (2012)
Clinical and Immunological Correction of DOCK8 Deficiency by Allogeneic Hematopoietic Stem Cell Transplantation Following a Reduced Toxicity Conditioning RegimenPediatric Hematology and Oncology, 29
T. Güngör, P. Teira, M. Slatter, G. Stussi, P. Stepensky, D. Moshous, C. Vermont, I. Ahmad, Peter Shaw, José Cunha, P. Schlegel, R. Hough, A. Fasth, K. Kentouche, B. Gruhn, Juliana Fernandes, S. Lachance, R. Bredius, I. Resnick, Bernd Belohradsky, A. Gennery, A. Fischer, H. Gaspar, U. Schanz, R. Seger, K. Rentsch, P. Veys, E. Haddad, Michael Albert, Moustapha Hassan (2014)
Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre studyThe Lancet, 383
N. Cooper, K. Rao, K. Gilmour, L. Hadad, S. Adams, C. Cale, G. Davies, D. Webb, P. Veys, P. Amrolia (2006)
Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis.Blood, 107 3
J. Schmid, Chen-Hsuan Ho, F. Chrétien, Juliette Lefebvre, G. Pivert, M. Kosco-Vilbois, W. Ferlin, F. Geissmann, A. Fischer, G. Basile (2009)
Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient miceEMBO Molecular Medicine, 1
This study shows that a reduced-intensity conditioning regimen is well tolerated and efficacious in high-risk patients with CGD
A. Gennery, M. Slatter, L. Grandin, P. Taupin, A. Cant, P. Veys, P. Amrolia, H. Gaspar, E. Davies, W. Friedrich, M. Hoenig, L. Notarangelo, E. Mazzolari, F. Porta, R. Bredius, A. Lankester, N. Wulffraat, R. Seger, A. Fasth, P. Sedláček, B. Neven, S. Blanche, A. Fischer, M. Cavazzana‐Calvo, P. Landais (2010)
Immune deficiencies , infection , and systemic immune disorders Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe : Entering a new century , do we do better ?
J. Schmid, D. Canioni, D. Moshous, F. Touzot, N. Mahlaoui, F. Hauck, H. Kanegane, E. López-Granados, E. Mejstrikova, I. Pellier, L. Galicier, C. Galambrun, V. Barlogis, P. Bordigoni, A. Fourmaintraux, M. Hamidou, A. Dabadie, F. Deist, F. Haerynck, M. Ouachée-Chardin, P. Rohrlich, J. Stéphan, C. Lenoir, S. Rigaud, N. Lambert, M. Milili, C. Schiff, H. Chapel, C. Picard, G. Basile, S. Blanche, A. Fischer, S. Latour (2011)
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).Blood, 117 5
M. Ouachée-Chardin, C. Elie, G. Basile, F. Deist, N. Mahlaoui, C. Picard, B. Neven, J. Casanova, M. Tardieu, M. Cavazzana‐Calvo, S. Blanche, A. Fischer (2006)
Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis: A Single-Center Report of 48 PatientsPediatrics, 117
K. Imai, S. Nonoyama, H. Ochs (2003)
WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotypeCurrent Opinion in Allergy and Clinical Immunology, 3
A. Metin, B. Tavil, F. Azik, D. Azkur, İkbal Ok-Bozkaya, C. Kocabaş, B. Tunç, D. Uçkan (2012)
Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndromePediatric Transplantation, 16
G. Basile, Gaël Ménasché, A. Fischer (2010)
Molecular mechanisms of biogenesis and exocytosis of cytotoxic granulesNature Reviews Immunology, 10
S. Hambleton, Sandra Salem, J. Bustamante, V. Bigley, S. Boisson-Dupuis, Joana Azevedo, A. Fortin, M. Haniffa, L. Ceron-Gutierrez, C. Bacon, G. Menon, Céline Trouillet, David McDonald, P. Carey, F. Ginhoux, L. Alsina, Timothy Zumwalt, X. Kong, D. Kumararatne, K. Butler, Marjorie Hubeau, J. Feinberg, S. Al‐Muhsen, A. Cant, L. Abel, D. Chaussabel, R. Doffinger, E. Talesnik, A. Grumach, A. Duarte, K. Abarca, D. Moraes-Vasconcelos, D. Burk, A. Berghuis, F. Geissmann, M. Collin, J. Casanova, P. Gros (2011)
IRF8 mutations and human dendritic-cell immunodeficiency.The New England journal of medicine, 365 2
R. Marsh, G. Vaughn, Mi‐Ok Kim, Dandan Li, S. Jodele, S. Joshi, P. Mehta, S. Davies, M. Jordan, J. Bleesing, A. Filipovich (2010)
Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.Blood, 116 26
R. Naithani, M. Asim, A. Naqvi, S. Weitzman, A. Gassas, J. Doyle, T. Schechter (2013)
Increased complications and morbidity in children with hemophagocytic lymphohistiocytosis undergoing hematopoietic stem cell transplantationClinical Transplantation, 27
J. Greil, T. Rausch, T. Giese, O. Bandapalli, V. Daniel, I. Bekeredjian-Ding, A. Stütz, Christoph Drees, S. Roth, J. Ruland, J. Korbel, A. Kulozik (2013)
Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency.The Journal of allergy and clinical immunology, 131 5
S. Hacein-Bey-Abina, J. Hauer, A. Lim, C. Picard, Gary Wang, C. Berry, C. Martinache, F. Rieux-Laucat, S. Latour, B. Belohradsky, L. Leiva, R. Sorensen, M. Debré, J. Casanova, S. Blanche, A. Durandy, F. Bushman, A. Fischer, M. Cavazzana‐Calvo (2010)
Efficacy of gene therapy for X-linked severe combined immunodeficiency.The New England journal of medicine, 363 4
C. Reimann, E. Six, L. Dal-Cortivo, A. Schiavo, K. Appourchaux, C. Lagresle-Peyrou, C. Chappedelaine, B. Ternaux, L. Coulombel, K. Beldjord, M. Cavazzana‐Calvo, I. André-Schmutz (2012)
Human T-Lymphoid Progenitors Generated in a Feeder-Cell-Free Delta-Like-4 Culture System Promote T-Cell Reconstitution in NOD/SCID/γc−/− MiceStem Cells (Dayton, Ohio), 30
(2013)
This important work reports the results of the first lentivirus-mediated gene therapy for the WAS
T. Cole, M. Pearce, A. Cant, C. Cale, D. Goldblatt, A. Gennery (2013)
Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation.The Journal of allergy and clinical immunology, 132 5
Huie Jing, Qian Zhang, Yu Zhang, Brenna Hill, Christopher Dove, Erwin Gelfand, T. Atkinson, G. Uzel, Helen Matthews, P. Mustillo, David Lewis, Fotini Kavadas, I. Hanson, Ashish Kumar, R. Geha, Daniel Douek, Steven Holland, A. Freeman, H. Su (2014)
Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype.The Journal of allergy and clinical immunology, 133 6
R. Marsh, K. Rao, P. Satwani, K. Lehmberg, I. Müller, Dandan Li, Mi‐Ok Kim, A. Fischer, S. Latour, P. Sedláček, V. Barlogis, K. Hamamoto, H. Kanegane, Samuel Milanovich, D. Margolis, D. Dimmock, J. Casper, Dorothea Douglas, P. Amrolia, P. Veys, Ashish Kumar, M. Jordan, J. Bleesing, A. Filipovich (2013)
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.Blood, 121 6
A. Aiuti, L. Biasco, S. Scaramuzza, F. Ferrua, M. Cicalese, C. Baricordi, F. Dionisio, A. Calabria, S. Giannelli, M. Castiello, M. Bosticardo, Costanza Evangelio, A. Assanelli, Miriam Casiraghi, S. Nunzio, Luciano Callegaro, C. Benati, P. Rizzardi, D. Pellin, C. Serio, M. Schmidt, C. Kalle, J. Gardner, Nalini Mehta, Victor Neduva, D. Dow, A. Galy, R. Miniero, A. Finocchi, A. Metin, P. Banerjee, J. Orange, S. Galimberti, M. Valsecchi, A. Biffi, E. Montini, A. Villa, F. Ciceri, M. Roncarolo, L. Naldini (2013)
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich SyndromeScience, 341
C. Martinez, Sweta Shah, W. Shearer, H. Rosenblatt, M. Paul, J. Chinen, K. Leung, A. Kennedy-Nasser, M. Brenner, H. Heslop, Hao Liu, Meng-fen Wu, I. Hanson, R. Krance (2012)
Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.The Journal of allergy and clinical immunology, 129 1
Lucinda Brown, J. Xu-Bayford, Z. Allwood, M. Slatter, A. Cant, E. Davies, P. Veys, A. Gennery, H. Gaspar, H. Gaspar (2011)
Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening.Blood, 117 11
R. Dickinson, H. Griffin, V. Bigley, L. Reynard, Rafiqul Hussain, M. Haniffa, J. Lakey, T. Rahman, Xiao‐nong Wang, N. McGovern, S. Pagan, S. Cookson, David McDonald, I. Chua, J. Wallis, A. Cant, M. Wright, B. Keavney, P. Chinnery, J. Loughlin, S. Hambleton, M. Santibanez-Koref, M. Collin (2011)
Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency.Blood, 118 10
Qian Zhang, Jeremiah Davis, Ian Lamborn, A. Freeman, Huie Jing, Amanda Favreau, Helen Matthews, Joie Davis, M. Turner, G. Uzel, S. Holland, H. Su (2009)
Combined immunodeficiency associated with DOCK8 mutations.The New England journal of medicine, 361 21
C. Terrell, M. Jordan (2013)
Mixed hematopoietic or T-cell chimerism above a minimal threshold restores perforin-dependent immune regulation in perforin-deficient mice.Blood, 122 15
D. Moratto, S. Giliani, C. Bonfim, E. Mazzolari, A. Fischer, H. Ochs, A. Cant, A. Thrasher, M. Cowan, M. Albert, T. Small, S. Pai, E. Haddad, A. Lisa, S. Hambleton, M. Slatter, M. Cavazzana‐Calvo, N. Mahlaoui, C. Picard, T. Torgerson, L. Burroughs, A. Koliski, J. Neto, F. Porta, W. Qasim, P. Veys, K. Kavanau, M. Hönig, A. Schulz, W. Friedrich, L. Notarangelo (2011)
Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study.Blood, 118 6
REVIEW URRENT Stem cell transplantation for primary PINION immunodeficiencies: the European experience a,b,c,d a,b,c,e c,e Marina Cavazzana , Fabien Touzot , Despina Moshous , c,e c,e c,d,e,f Be´ne´dicte Neven , Ste´phane Blanche , and Alain Fischer Purpose of review Primary immunodeficiencies (PIDs) constitute a heterogeneous group of inherited disorders affecting the development and/or function of the immune system. This review focuses on the recent advances in hematopoietic stem cell transplantation (HSCT) for PIDs, as it remains the only potentially curative option for many of these diseases. Recent findings We report on the most recent HSCT European results and suggest some opportunities for better treatment of certain PIDs. Progress on gene therapy is also discussed, as it emerges as an interesting option for PIDs management. Summary Progress in the treatment of primary immune deficiency with HSCT requires a better understanding of the pathophysiology and specificity of each of these diseases, allowing us to determine the best options in terms of donor, conditioning regimen, modification of the allograft and immunosuppressive therapy. Alternative therapies – such as gene therapy – emerge as an interesting option for some PIDs. Keywords gene therapy, hematopoietic stem cell transplantation, immunological reconstitution, primary immunodeficiencies INTRODUCTION SEVERE COMBINED
Current Opinion in Allergy and Clinical Immunology – Wolters Kluwer Health
Published: Dec 1, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.